{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:52Z","timestamp":1787032852195,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"DOI":"10.7759\/cureus.81921","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:16:26Z","timestamp":1744154186000},"source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Varicella-Zoster Virus in a Patient on Pegloticase and Mycophenolate Mofetil for Gout"],"prefix":"10.7759","author":[{"given":"Sylvia","family":"Riad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly D","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth N","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016, 388:2039-52. 10.1016\/S0140-6736(16)00346-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199668847.003.0039","article-title":"Pathophysiology of gout","author":"Dalbeth N","year":"2016","unstructured":"Dalbeth N. Pathophysiology of gout. Oxford Textbook of Osteoarthritis and Crystal Arthropathy. Oxford University Press, Oxford, United Kingdom; 2016. 389-400. 10.1093\/med\/9780199668847.003.0039"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05902-5","article-title":"Hospital admission risk stratification of patients with gout presenting to the emergency department","volume":"41","author":"Han W","year":"2022","unstructured":"Han W, Allameen NA, Ibrahim I, Dhanasekaran P, Mengling F, Lahiri M. Hospital admission risk stratification of patients with gout presenting to the emergency department. Clin Rheumatol. 2022, 41:1801-7. 10.1007\/s10067-021-05902-5","journal-title":"Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1877-0","article-title":"An update on the pathology and clinical management of gouty arthritis","volume":"31","author":"Gonzalez EB","year":"2012","unstructured":"Gonzalez EB. An update on the pathology and clinical management of gouty arthritis. Clin Rheumatol. 2012, 31:13-21. 10.1007\/s10067-011-1877-0","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2020.12.001","article-title":"Pathophysiology of gout","volume":"40","author":"Narang RK","year":"2020","unstructured":"Narang RK, Dalbeth N. Pathophysiology of gout. Semin Nephrol. 2020, 40:550-63. 10.1016\/j.semnephrol.2020.12.001","journal-title":"Semin Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians","volume":"166","author":"Qaseem A","year":"2017","unstructured":"Qaseem A, Harris RP, Forciea MA, et al.. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017, 166:58-68. 10.7326\/M16-0570","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.04.010","article-title":"Therapeutic approaches in the treatment of gout","volume":"50","author":"Pillinger MH","year":"2020","unstructured":"Pillinger MH, Mandell BF. Therapeutic approaches in the treatment of gout. Semin Arthritis Rheum. 2020, 50:S24-30. 10.1016\/j.semarthrit.2020.04.010","journal-title":"Semin Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald JD","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al.. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken). 2020, 72:744-60. 10.1002\/acr.24180","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.126","article-title":"Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)","volume":"13","author":"Dalbeth N","year":"2017","unstructured":"Dalbeth N, Bardin T, Doherty M, et al.. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN). Nat Rev Rheumatol. 2017, 13:561-8. 10.1038\/nrrheum.2017.126","journal-title":"Nat Rev Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.01.005","article-title":"The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review","volume":"51","author":"Keenan RT","year":"2021","unstructured":"Keenan RT, Botson JK, Masri KR, Padnick-Silver L, LaMoreaux B, Albert JA, Pillinger MH. The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review. Semin Arthritis Rheum. 2021, 51:347-52. 10.1016\/j.semarthrit.2021.01.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000200","article-title":"Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy","volume":"20","author":"Baraf HS","year":"2014","unstructured":"Baraf HS, Yood RA, Ottery FD, Sundy JS, Becker MA. Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy. J Clin Rheumatol. 2014, 20:427-32. 10.1097\/RHU.0000000000000200","journal-title":"J Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.41731","article-title":"Reducing immunogenicity of pegloticase with concomitant use of mycophenolate mofetil in patients with refractory gout: a phase II, randomized, double\u2010blind, placebo\u2010controlled trial","volume":"73","author":"Khanna PP","year":"2021","unstructured":"Khanna PP, Khanna D, Cutter G, et al.. Reducing immunogenicity of pegloticase with concomitant use of mycophenolate mofetil in patients with refractory gout: a phase II, randomized, double\u2010blind, placebo\u2010controlled trial. Arthritis Rheumatol. 2021, 73:1523-32. 10.1002\/art.41731","journal-title":"Arthritis Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2109oa","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison AC","year":"2005","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005, 14:s2-8. 10.1191\/0961203305lu2109oa","journal-title":"Lupus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(03)00684-5","article-title":"Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil","volume":"35","author":"Lauzurica R","year":"2003","unstructured":"Lauzurica R, Bay\u00e9s B, Fr\u00edas C, et al.. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003, 35:1758-9. 10.1016\/s0041-1345(03)00684-5","journal-title":"Transplant Proc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0012.2000.14041002.x","article-title":"Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation","volume":"14","author":"Triemer HL","year":"2000","unstructured":"Triemer HL, Pearson TC, Odom KL, Larsen CP. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation. Clin Transplant. 2000, 14:413-20. 10.1034\/j.1399-0012.2000.14041002.x","journal-title":"Clin Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/344998-disseminated-varicella-zoster-virus-in-a-patient-on-pegloticase-and-mycophenolate-mofetil-for-gout","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:16:27Z","timestamp":1744154187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/344998-disseminated-varicella-zoster-virus-in-a-patient-on-pegloticase-and-mycophenolate-mofetil-for-gout"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.81921","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}